later-line treatment for mcrc: regorafenib or tas-102?
Published 5 years ago • 345 plays • Length 2:13Download video MP4
Download video MP3
Similar videos
-
4:53
debate: salvage therapy for mcrc? - tas-102 followed by regorafenib
-
7:54
regorafenib vs tas-102 salvage therapy
-
2:47
mcrc: sequencing with regorafenib or tas-102
-
1:16
dr. bekaii-saab on tas-102 and regorafenib in mcrc
-
1:35
dr. lockhart on next steps for regorafenib and tas-102 in mcrc
-
5:56
future directions for later-line therapy in r/r mcrc
-
4:54
the first oral fluoropyrimidine for mcrc—tas-102
-
12:47
debate: salvage therapy for mcrc? regorafenib followed by tas-102
-
6:30
sequencing in mcrc: later-line therapies
-
1:12
dr. lenz on choosing between regorafenib and tas-102 in crc
-
5:02
third-line treatment options for mcrc
-
11:02
debate 3: salvage therapy for mcrc? - regorafenib
-
1:28
dr. overman on distinctions between regorafenib and tas-102 in crc
-
9:06
debate: is there an optimal treatment for refractory colorectal cancer? - tas-102 or regorafenib
-
0:20
copy of dr. bekaii-saab on tas-102 and regorafenib in mcrc
-
7:35
use of regorafenib in refractory mcrc
-
8:04
first- and second-line treatment for mcrc in specific populations
-
1:16
dr. eng on roles of regorafenib and tas-102 in crc treatment
-
13:46
debate 3: salvage therapy for mcrc? - tas-102